Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Neurovascular Devices Market: By Device Type, By Therapeutic Application, By End User and Geography
Neurovascular Devices Market size was valued at 2.69 Billion in 2023 and is estimated to reach 4.69 Billion by 2030, at a CAGR of 7.4% from 2024 to 2030. Some of the factors propelling the market growth to the rising geriatric population they have a greater risk to prone various diseases and disorders such as cerebrovascular, neurological, and others. Additionally, accessibility to advanced medical facilities for diagnosis and treatment will positively impact the market growth. Furthermore, upgrading in technology and new advanced innovations in the medical facility will fuel the market growth. However, the high cost of the treatment, lack of skilled professionals, and lack of awareness among the individuals will hinder the market growth. Aneurysms are caused by an increase in the prevalence of hypertension, alcohol intake, and smoking. An estimated 6 million Americans are impacted by brain aneurysms each year, according to the Brain Aneurysm Foundation. Every year, the disease claims the lives of half a million people around the world. In the creation of neurothrombectomy devices for the treatment of AIS and accompanying symptoms, a variety of additional technologies are applied. As a result, market expansion is likely to be fueled by the launch of technologically improved items and a quick product approval procedure.
Study Period
2024-2030Base Year
2023CAGR
8.3%Largest Market
North AmericaFastest Growing Market
Asia pacific
Due to changing lifestyle and rising in the old aged population increasing in the prevalence of numerous of disease and disorders such as neurovascular, and others. Due to modern advance equipped medical sector which provide better medical facilities for earlier diagnosis and treatment propelling the market growth. Additionally, key players are concentrating on developing cost-effective advance medical devices which technological advance and easy to access. Moreover, favorable medical reimbursements and government initiation on the healthcare sector will positively impact on the market growth.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market CAGR |
8.3% |
By Device Type |
|
By Therapeutic |
|
By End User |
|
Download Free Sample Report
The neurovascular devices market size was valued at US$ 2.69 billion in 2022
The neurovascular devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The neurovascular devices market key players are: Abbott Laboratories, Johnson & Johnson Services, Inc., Merit Medical Systems, Inc., L. Gore & Associates, Inc., Penumbra, Inc., Terumo Medical Corporation, MicroPort Scientific Corporation, Medtronic PLC, Stryker Corp, Asahi Intecc Co. Ltd., Boston Scientific Corporation, Kaneka Medix Corp, MicroPort Scientific Corporation, LivaNova PLC, Integer Holdings Corporation
1. Executive Summary |
2. Global Neurovascular Devices Market Introduction |
2.1.Global Neurovascular Devices Market - Taxonomy |
2.2.Global Neurovascular Devices Market - Definitions |
2.2.1. Device Type |
2.2.2.Therapeutic |
2.2.3.End Users |
2.2.4.Region |
3. Global Neurovascular Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Neurovascular Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Neurovascular Devices Market By Device Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Cerebral Angioplasty and Stenting Systems |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Carotid Artery Stents |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Embolic Protection Systems |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Neurothrombectomy Devices |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Cerebral Embolization and Aneurysm Coiling Devices |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Embolic Coils |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Flow Diversion Devices |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Liquid Embolic Agents |
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
5.9. Support Devices |
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.9.3. Market Opportunity Analysis |
5.10. Micro Catheters |
5.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.10.3. Market Opportunity Analysis |
5.11. Micro Guidewires |
5.11.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.11.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.11.3. Market Opportunity Analysis |
5.12. Clot Retrieval |
5.12.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.12.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.12.3. Market Opportunity Analysis |
6. Global Neurovascular Devices Market By Therapeutic, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Stroke |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Cerebral Artery Stenosis |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Cerebral Aneurysm |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Neurovascular Devices Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Clinics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Ambulatory Surgical Centers |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Neurovascular Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Neurovascular Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Cerebral Angioplasty and Stenting Systems |
9.1.2.Carotid Artery Stents |
9.1.3.Embolic Protection Systems |
9.1.4.Neurothrombectomy Devices |
9.1.5.Cerebral Embolization and Aneurysm Coiling Devices |
9.1.6.Embolic Coils |
9.1.7.Flow Diversion Devices |
9.1.8.Liquid Embolic Agents |
9.1.9.Support Devices |
9.1.10.Micro Catheters |
9.1.11.Micro Guidewires |
9.1.12.Clot Retrieval |
9.2. Suction Therapeutic Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Stroke |
9.2.2.Cerebral Artery Stenosis |
9.2.3.Cerebral Aneurysm |
9.2.4.Others |
9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Clinics |
9.3.3.Ambulatory Surgical Centers |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Neurovascular Devices Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Cerebral Angioplasty and Stenting Systems |
10.1.2.Carotid Artery Stents |
10.1.3.Embolic Protection Systems |
10.1.4.Neurothrombectomy Devices |
10.1.5.Cerebral Embolization and Aneurysm Coiling Devices |
10.1.6.Embolic Coils |
10.1.7.Flow Diversion Devices |
10.1.8.Liquid Embolic Agents |
10.1.9.Support Devices |
10.1.10.Micro Catheters |
10.1.11.Micro Guidewires |
10.1.12.Clot Retrieval |
10.2. Therapeutic Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Stroke |
10.2.2.Cerebral Artery Stenosis |
10.2.3.Cerebral Aneurysm |
10.2.4.Others |
10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Clinics |
10.3.3.Ambulatory Surgical Centers |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Neurovascular Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Cerebral Angioplasty and Stenting Systems |
11.1.2.Carotid Artery Stents |
11.1.3.Embolic Protection Systems |
11.1.4.Neurothrombectomy Devices |
11.1.5.Cerebral Embolization and Aneurysm Coiling Devices |
11.1.6.Embolic Coils |
11.1.7.Flow Diversion Devices |
11.1.8.Liquid Embolic Agents |
11.1.9.Support Devices |
11.1.10.Micro Catheters |
11.1.11.Micro Guidewires |
11.1.12.Clot Retrieval |
11.2. Therapeutic Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Stroke |
11.2.2.Cerebral Artery Stenosis |
11.2.3.Cerebral Aneurysm |
11.2.4.Others |
11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Clinics |
11.3.3.Ambulatory Surgical Centers |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Neurovascular Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Cerebral Angioplasty and Stenting Systems |
12.1.2.Carotid Artery Stents |
12.1.3.Embolic Protection Systems |
12.1.4.Neurothrombectomy Devices |
12.1.5.Cerebral Embolization and Aneurysm Coiling Devices |
12.1.6.Embolic Coils |
12.1.7.Flow Diversion Devices |
12.1.8.Liquid Embolic Agents |
12.1.9.Support Devices |
12.1.10.Micro Catheters |
12.1.11.Micro Guidewires |
12.1.12.Clot Retrieval |
12.2. Therapeutic Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Stroke |
12.2.2.Cerebral Artery Stenosis |
12.2.3.Cerebral Aneurysm |
12.2.4.Others |
12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Clinics |
12.3.3.Ambulatory Surgical Centers |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Neurovascular Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Cerebral Angioplasty and Stenting Systems |
13.1.2.Carotid Artery Stents |
13.1.3.Embolic Protection Systems |
13.1.4.Neurothrombectomy Devices |
13.1.5.Cerebral Embolization and Aneurysm Coiling Devices |
13.1.6.Embolic Coils |
13.1.7.Flow Diversion Devices |
13.1.8.Liquid Embolic Agents |
13.1.9.Support Devices |
13.1.10.Micro Catheters |
13.1.11.Micro Guidewires |
13.1.12.Clot Retrieval |
13.2. Therapeutic Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Stroke |
13.2.2.Cerebral Artery Stenosis |
13.2.3.Cerebral Aneurysm |
13.2.4.Others |
13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Clinics |
13.3.3.Ambulatory Surgical Centers |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Abbott Laboratories |
14.2.2.Johnson & Johnson Services, Inc. |
14.2.3.Merit Medical Systems, Inc. |
14.2.4.W. L. Gore & Associates, Inc. |
14.2.5.Penumbra, Inc. |
14.2.6.Terumo Medical Corporation |
14.2.7.MicroPort Scientific Corporation |
14.2.8.Medtronic PLC |
14.2.9.Stryker Corp |
14.2.10.Asahi Intecc Co. Ltd. |
14.2.11.Boston Scientific Corporation |
14.2.12.Kaneka Medix Corp |
14.2.13.MicroPort Scientific Corporation |
14.2.14.LivaNova PLC |
14.2.15.Integer Holdings Corporation |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players